1. Home
  2. ALLO vs WEYS Comparison

ALLO vs WEYS Comparison

Compare ALLO & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$31.50

Market Cap

280.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
WEYS
Founded
2017
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
280.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
WEYS
Price
$1.80
$31.50
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$8.27
N/A
AVG Volume (30 Days)
6.3M
9.1K
Earning Date
03-12-2026
03-03-2026
Dividend Yield
N/A
3.43%
EPS Growth
N/A
N/A
EPS
N/A
2.54
Revenue
N/A
$279,843,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.40
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$25.51
52 Week High
$3.78
$37.19

Technical Indicators

Market Signals
Indicator
ALLO
WEYS
Relative Strength Index (RSI) 58.49 50.06
Support Level $1.56 $31.10
Resistance Level $1.84 $33.48
Average True Range (ATR) 0.16 0.79
MACD -0.01 -0.02
Stochastic Oscillator 67.96 44.51

Price Performance

Historical Comparison
ALLO
WEYS

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: